TY - JOUR
T1 - Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer
AU - Sathianathen, Niranjan J.
AU - Philippou, Yiannis A.
AU - Kuntz, Gretchen M.
AU - Konety, Badrinath R.
AU - Lamb, Alastair D.
AU - Dahm, Philipp
N1 - Publisher Copyright:
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2017/9/30
Y1 - 2017/9/30
N2 - © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of immediate taxane-based chemohormonal therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.
AB - © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of immediate taxane-based chemohormonal therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.
UR - http://www.scopus.com/inward/record.url?scp=85030155357&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030155357&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD012816
DO - 10.1002/14651858.CD012816
M3 - Article
AN - SCOPUS:85030155357
SN - 1361-6137
VL - 2017
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 9
M1 - CD012816
ER -
